Liu X, Yan G, Pang J, Xiao Z, et al. The Systemic Immune-Inflammation Index is a Predictor of Chemotherapy Sensitivity and Disease-Free Survival in Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. Clin Breast Cancer 2024 Oct 1:S1526-8209(24)00275.
PMID: 39448293